Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $151.5300 (0.34%) ($151.5300 - $153.4300) on Tue. Apr. 27, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.84% (three month average) | RSI | 47 | Latest Price | $151.5300(0.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.6% a day on average for past five trading days. | Weekly Trend | LGND declines -0.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(57%) IWM(54%) IWC(52%) XBI(51%) | Factors Impacting LGND price | LGND will decline at least -2.42% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-16%) UNG(-3%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.42% (StdDev 4.84%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $149.76(1.18%) | 10 Day Moving Average | $149.17(1.58%) | 20 Day Moving Average | $150.38(0.76%) | To recent high | -29.8% | To recent low | 9% | Market Cap | $2.435b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |